151 related articles for article (PubMed ID: 29620286)
21. Astragalus polysaccharide inhibits breast cancer cell migration and invasion by regulating epithelial‑mesenchymal transition via the Wnt/β‑catenin signaling pathway.
Yang S; Sun S; Xu W; Yu B; Wang G; Wang H
Mol Med Rep; 2020 Apr; 21(4):1819-1832. PubMed ID: 32319619
[TBL] [Abstract][Full Text] [Related]
22. Febuxostat inhibits TGF‑β1‑induced epithelial‑mesenchymal transition via downregulation of USAG‑1 expression in Madin‑Darby canine kidney cells in vitro.
Lu L; Zhu J; Zhang Y; Wang Y; Zhang S; Xia A
Mol Med Rep; 2019 Mar; 19(3):1694-1704. PubMed ID: 30628645
[TBL] [Abstract][Full Text] [Related]
23. Diallyl disulfide selectively causes checkpoint kinase-1 mediated G2/M arrest in human MGC803 gastric cancer cell line.
Ling H; Lu LF; He J; Xiao GH; Jiang H; Su Q
Oncol Rep; 2014 Nov; 32(5):2274-82. PubMed ID: 25176258
[TBL] [Abstract][Full Text] [Related]
24. A novel anthraquinone‑quinazoline hybrid 7B blocks breast cancer metastasis and EMT via targeting EGFR and Rac1.
Kang J; Zhong Y; Tian W; Li J; Li X; Zhai L; Hou H; Li D
Int J Oncol; 2021 May; 58(5):. PubMed ID: 33760108
[TBL] [Abstract][Full Text] [Related]
25. JMJD2B promotes epithelial-mesenchymal transition by cooperating with β-catenin and enhances gastric cancer metastasis.
Zhao L; Li W; Zang W; Liu Z; Xu X; Yu H; Yang Q; Jia J
Clin Cancer Res; 2013 Dec; 19(23):6419-29. PubMed ID: 24077348
[TBL] [Abstract][Full Text] [Related]
26. Melatonin attenuates TGFβ1-induced epithelial-mesenchymal transition in lung alveolar epithelial cells.
Yu N; Sun YT; Su XM; He M; Dai B; Kang J
Mol Med Rep; 2016 Dec; 14(6):5567-5572. PubMed ID: 27878256
[TBL] [Abstract][Full Text] [Related]
27. Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling.
Xie X; Huang X; Tang H; Ye F; Yang L; Guo X; Tian Z; Xie X; Peng C; Xie X
Curr Cancer Drug Targets; 2018; 18(6):592-599. PubMed ID: 29110616
[TBL] [Abstract][Full Text] [Related]
28. [Diallyl disulfide inhibits invasion and metastasis of MCF-7 breast cancer cells in vitro by down-regulating p38 activity].
Chen XX; Liu XW; Zhou ZG; Chen XY; Li LD; Xiong T; Peng L; Tu J
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(6):814-8. PubMed ID: 27320884
[TBL] [Abstract][Full Text] [Related]
29. miR‑483‑5p promotes growth, invasion and self‑renewal of gastric cancer stem cells by Wnt/β‑catenin signaling.
Wu K; Ma L; Zhu J
Mol Med Rep; 2016 Oct; 14(4):3421-8. PubMed ID: 27511210
[TBL] [Abstract][Full Text] [Related]
30. Astragaloside IV inhibits the invasion and metastasis of SiHa cervical cancer cells via the TGF‑β1‑mediated PI3K and MAPK pathways.
Zhang L; Zhou J; Qin X; Huang H; Nie C
Oncol Rep; 2019 May; 41(5):2975-2986. PubMed ID: 30896841
[TBL] [Abstract][Full Text] [Related]
31. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
32. Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22.
Tang H; Kong Y; Guo J; Tang Y; Xie X; Yang L; Su Q; Xie X
Cancer Lett; 2013 Oct; 340(1):72-81. PubMed ID: 23851184
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia-inducible factor-1α and Wnt/β-catenin signaling pathways promote the invasion of hypoxic gastric cancer cells.
Liu HL; Liu D; Ding GR; Liao PF; Zhang JW
Mol Med Rep; 2015 Sep; 12(3):3365-3373. PubMed ID: 25997455
[TBL] [Abstract][Full Text] [Related]
34. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
Menezes ME; Shen XN; Das SK; Emdad L; Sarkar D; Fisher PB
Oncotarget; 2016 Dec; 7(49):80175-80189. PubMed ID: 27863394
[TBL] [Abstract][Full Text] [Related]
35. Role of transforming growth factor β1 in the inhibition of gastric cancer cell proliferation by melatonin in vitro and in vivo.
Liu H; Zhu Y; Zhu H; Cai R; Wang KF; Song J; Wang RX; Zhou RX
Oncol Rep; 2019 Aug; 42(2):753-762. PubMed ID: 31173264
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of LIMK1-ADF/cofilin by DADS inhibits the migration and invasion of colon cancer.
Su J; Zhou Y; Pan Z; Shi L; Yang J; Liao A; Liao Q; Su Q
Sci Rep; 2017 Mar; 7():45624. PubMed ID: 28358024
[TBL] [Abstract][Full Text] [Related]
37. [Inhibitory effect of diallyl disulfide on proliferation of human colon cancer cell line SW480 in nude mice].
Liao QJ; Su J; Zhou XT; Tang HL; Song Y; Su Q
Ai Zheng; 2007 Aug; 26(8):828-32. PubMed ID: 17697541
[TBL] [Abstract][Full Text] [Related]
38. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
39. Diallyl disulfide inhibits colon cancer metastasis by suppressing Rac1-mediated epithelial-mesenchymal transition.
Xia L; Lin J; Su J; Oyang L; Wang H; Tan S; Tang Y; Chen X; Liu W; Luo X; Tian Y; Liang J; Su Q; Liao Q; Zhou Y
Onco Targets Ther; 2019; 12():5713-5728. PubMed ID: 31410018
[TBL] [Abstract][Full Text] [Related]
40. Ginsenoside Rg1 attenuates invasion and migration by inhibiting transforming growth factor-β1-induced epithelial to mesenchymal transition in HepG2 cells.
Yu M; Yu X; Guo D; Yu B; Li L; Liao Q; Xing R
Mol Med Rep; 2015 Apr; 11(4):3167-73. PubMed ID: 25515352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
